artience Valuation

Is TO5 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of TO5 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: TO5 (€18.9) is trading below our estimate of fair value (€86.93)

Significantly Below Fair Value: TO5 is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for TO5?

Key metric: As TO5 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for TO5. This is calculated by dividing TO5's market cap by their current earnings.
What is TO5's PE Ratio?
PE Ratio10.7x
EarningsJP¥15.14b
Market CapJP¥161.61b

Price to Earnings Ratio vs Peers

How does TO5's PE Ratio compare to its peers?

The above table shows the PE ratio for TO5 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average18.4x
ACT AlzChem Group
11.6x12.6%€582.1m
UZU Uzin Utz
10.5x2.1%€250.2m
WCH Wacker Chemie
28.3x37.0%€3.5b
2HRA H&R GmbH KGaA
23.4x52.9%€129.2m
TO5 artience
10.7x6.6%€161.6b

Price-To-Earnings vs Peers: TO5 is good value based on its Price-To-Earnings Ratio (10.7x) compared to the peer average (18.4x).


Price to Earnings Ratio vs Industry

How does TO5's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
TO5 10.7xIndustry Avg. 16.8xNo. of Companies12PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: TO5 is good value based on its Price-To-Earnings Ratio (10.7x) compared to the European Chemicals industry average (17.3x).


Price to Earnings Ratio vs Fair Ratio

What is TO5's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

TO5 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio10.7x
Fair PE Ratio13.5x

Price-To-Earnings vs Fair Ratio: TO5 is good value based on its Price-To-Earnings Ratio (10.7x) compared to the estimated Fair Price-To-Earnings Ratio (13.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst TO5 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€18.90
€29.67
+57.0%
1.0%€29.98€29.36n/a2
Nov ’25€21.20
€28.61
+34.9%
6.5%€30.47€26.74n/a2
Oct ’25€23.60
€28.61
+21.2%
6.5%€30.47€26.74n/a2
Sep ’25€22.80
€27.17
+19.2%
1.1%€27.48€26.86n/a2
Aug ’25€18.80
€25.84
+37.4%
1.1%€26.13€25.54n/a2
Jul ’25€18.90
€25.84
+36.7%
1.1%€26.13€25.54n/a2
Jun ’25€19.30
€23.88
+23.7%
8.6%€25.94€21.82n/a2
May ’25€17.10
€22.25
+30.1%
2.8%€22.86€21.63n/a2
Apr ’25€17.50
€22.25
+27.1%
2.8%€22.86€21.63n/a2
Mar ’25€16.90
€21.10
+24.9%
1.4%€21.41€20.80n/a2
Feb ’25€17.10
€20.37
+19.1%
4.6%€21.31€19.43n/a2
Jan ’25€16.40
€20.82
+27.0%
4.6%€21.79€19.86n/a2
Dec ’24€16.00
€20.14
+25.9%
4.6%€21.07€19.21n/a2
Nov ’24€15.80
€19.84
+25.6%
4.8%€20.79€18.90€21.202

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies